Your search returned 10 results.

Results
	1.	Structural and biochemical studies of the PDGFRA kinase domain. [electronic resource] by Liang, Ling Yan, Xiao-E Yin, Yuxin Yun, Cai-Hong Producer: 20170515 In: Biochemical and biophysical research communications vol. 477 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Structural basis of mutant-selectivity and drug-resistance related to CO-1686. [electronic resource] by Yan, Xiao-E Zhu, Su-Jie Liang, Ling Zhao, Peng Choi, Hwan Geun Yun, Cai-Hong Producer: 20170925 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Structural pharmacological studies on EGFR T790M/C797S. [electronic resource] by Kong, Lu-Lu Ma, Rui Yao, Ming-Yu Yan, Xiao-E Zhu, Su-Jie Zhao, Peng Yun, Cai-Hong Producer: 20170921 In: Biochemical and biophysical research communications vol. 488 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Structural insights into drug development strategy targeting EGFR T790M/C797S. [electronic resource] by Zhu, Su-Jie Zhao, Peng Yang, Jiao Ma, Rui Yan, Xiao-E Yang, Sheng-Yong Yang, Jing-Wen Yun, Cai-Hong Publication details: Oncotarget Mar 2018 In: Oncotarget vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A structure-guided optimization of pyrido[2,3-d]pyrimidin-7-ones as selective inhibitors of EGFR [electronic resource] by Yu, Lei Huang, Minhao Xu, Tianfeng Tong, Linjiang Yan, Xiao-E Zhang, Zhang Xu, Yong Yun, Caihong Xie, Hua Ding, Ke Lu, Xiaoyun Producer: 20170222 In: European journal of medicinal chemistry vol. 126 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFRα kinase inhibitor for PDGFRα driving chronic eosinophilic leukemia. [electronic resource] by Wang, Qiang Liu, Feiyang Qi, Shuang Qi, Ziping Yan, Xiao-E Wang, Beilei Wang, Aoli Wang, Wei Chen, Cheng Liu, Xiaochuan Jiang, Zongru Hu, Zhenquan Wang, Li Wang, Wenchao Ren, Tao Zhang, Shanchun Yun, Cai-Hong Liu, Qingsong Liu, Jing Producer: 20180426 In: European journal of medicinal chemistry vol. 150 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Discovery and characterization of a novel irreversible EGFR mutants selective and potent kinase inhibitor CHMFL-EGFR-26 with a distinct binding mode. [electronic resource] by Hu, Chen Wang, Aoli Wu, Hong Qi, Ziping Li, Xixiang Yan, Xiao-E Chen, Cheng Yu, Kailin Zou, Fengming Wang, Wenchao Wang, Wei Wu, Jiaxin Liu, Juan Wang, Beilei Wang, Li Ren, Tao Zhang, Shanchun Yun, Cai-Hong Liu, Jing Liu, Qingsong Producer: 20170929 In: Oncotarget vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode. [electronic resource] by Wang, Aoli Li, Xixiang Wu, Hong Zou, Fengming Yan, Xiao-E Chen, Cheng Hu, Chen Yu, Kailin Wang, Wenchao Zhao, Peng Wu, Jiaxin Qi, Ziping Wang, Wei Wang, Beilei Wang, Li Ren, Tao Zhang, Shanchun Yun, Cai-Hong Liu, Jing Liu, Qingsong Producer: 20170424 In: Journal of medicinal chemistry vol. 60 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Ibrutinib targets mutant-EGFR kinase with a distinct binding conformation. [electronic resource] by Wang, Aoli Yan, Xiao-E Wu, Hong Wang, Wenchao Hu, Chen Chen, Cheng Zhao, Zheng Zhao, Peng Li, Xixiang Wang, Li Wang, Beilei Ye, Zi Wang, Jinhua Wang, Chu Zhang, Wei Gray, Nathanael S Weisberg, Ellen L Chen, Liang Liu, Jing Yun, Cai-Hong Liu, Qingsong Producer: 20180213 In: Oncotarget vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Ibrutinib selectively and irreversibly targets EGFR (L858R, Del19) mutant but is moderately resistant to EGFR (T790M) mutant NSCLC Cells. [electronic resource] by Wu, Hong Wang, Aoli Zhang, Wei Wang, Beilei Chen, Cheng Wang, Wenchao Hu, Chen Ye, Zi Zhao, Zheng Wang, Li Li, Xixiang Yu, Kailin Liu, Juan Wu, Jiaxin Yan, Xiao-E Zhao, Peng Wang, Jinhua Wang, Chu Weisberg, Ellen L Gray, Nathanael S Yun, Cai-Hong Liu, Jing Chen, Liang Liu, Qingsong Producer: 20160823 In: Oncotarget vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)